2024
Brief Cognitive Behavioral Therapy for Suicidal Inpatients
Diefenbach G, Lord K, Stubbing J, Rudd M, Levy H, Worden B, Sain K, Bimstein J, Rice T, Everhardt K, Gueorguieva R, Tolin D. Brief Cognitive Behavioral Therapy for Suicidal Inpatients. JAMA Psychiatry 2024, 81: 1177-1186. PMID: 39259550, PMCID: PMC11391362, DOI: 10.1001/jamapsychiatry.2024.2349.Peer-Reviewed Original ResearchBrief cognitive behavioral therapyCognitive behavioral therapySubstance use disordersSuicidal ideationBehavioral therapySuicide attemptsFollow-up assessmentUse disorderOccurrence of suicide attemptsPsychiatric readmissionRates of psychiatric readmissionSuicide prevention treatmentsEffect of treatment conditionPrivate psychiatric hospitalTreatment effectsSuicidal inpatientsSuicide riskSuicidal crisisPsychiatric hospitalIndividual sessionsIdeationSuicide reattemptsPost hoc analysisSelf-reportBlinded interviewers
2022
mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression
Averill LA, Averill CL, Gueorguieva R, Fouda S, Sherif M, Ahn KH, Ranganathan M, D'Souza DC, Southwick SM, Sanacora G, Duman RS, Krystal JH, Abdallah CG. mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression. Journal Of Affective Disorders 2022, 303: 91-97. PMID: 35101523, DOI: 10.1016/j.jad.2022.01.104.Peer-Reviewed Original ResearchConceptsAntisuicidal effectsAntidepressant effectsSuicidal ideationKetamine-induced reductionTreatment-resistant depressionLimited treatment optionsCross-over trialMajor depressive episodeOral rapamycinPublic health crisisKetamine administrationTreatment optionsDepressive episodeParent studyOverall severityKetamineTwo weeksBeck ScaleRapamycin complex 1Mechanistic targetPatientsSignificant main effectHealth crisisRobust improvementFuture studies